The in vitro and in vivo anti-cancer potential of Mycobacterium cell wall fraction (MCWF) against canine transitional cell carcinoma of the urinary bladder - RIIP - Réseau International des Instituts Pasteur Accéder directement au contenu
Article Dans Une Revue Acta veterinaria Année : 2017

The in vitro and in vivo anti-cancer potential of Mycobacterium cell wall fraction (MCWF) against canine transitional cell carcinoma of the urinary bladder

Résumé

Transitional cell carcinoma (TCC), is the most common form of urinary bladder cancer in dogs and represents 2% of all reported canine cancers. Canine TCC is usually a high-grade invasive cancer and problems associated with TCC include urinary tract obstruction and distant metastases in more than 50% of affected dogs. TCC is most commonly located in the trigone region of the bladder precluding complete surgical resection. Current treatment options for TCC in dogs include medical therapy, surgery or radiation. Mycobacterium Cell Wall Fraction (MCWF) is a biological immunomodulator derived from non-pathogenic Mycobacterium phlei. MCWF possesses a potential in multiple veterinary areas such as anticancer therapy, palliative care and treatment of infectious diseases in both small and large animals. MCWF is considered a bifunctional anti-cancer agent that induces apoptosis of cancer cells and stimulates cytokine and chemokines synthesis by cells of the immune system. Here we report the results from in vitro and in vivo studies that could suggest use of MCWF as an additional treatment option for TCC in dogs. Particularly, we demonstrated that MCWF induces a concentration dependent inhibition of proliferation of K9TCC cells which was associated with the induction of apoptosis as measured by the proteolytic activation of caspase-3 and the degradation of PARP. Furthermore, we demonstrated the safety and potential for in vivo MCWF treatment efficacy in dogs bearing stage T2 TCC by reducing clinicals signs, and improving the quality of life in dogs with TCC.
Fichier principal
Vignette du fichier
476944baa3cd0d84ea226e51112b2845cca4f29d_03-Masic.indd.pdf (470.27 Ko) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

pasteur-01855896 , version 1 (08-08-2018)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

Mario C. Filion, Lucas Rodrigues, Chad Johannes, Aleksandar Masic. The in vitro and in vivo anti-cancer potential of Mycobacterium cell wall fraction (MCWF) against canine transitional cell carcinoma of the urinary bladder. Acta veterinaria, 2017, 67, 4, pp.477-494. ⟨10.1515/acve-2017-0039⟩. ⟨pasteur-01855896⟩

Collections

RIIP INRS-IAF
30 Consultations
151 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More